TranScrip Medical Affairs

TranScrip have a wide range of experience and expertise in supporting products at launch and during life-cycle management and can support a variety of medical affairs activities, including phase IV studies, development of advocacy and communication strategies or promotional materials.


TranScrip Medical Affairs Experts

TranScrip's Medical Affairs team has a wealth of expertise in pre- and post-launch activities across a number of different therapeutic areas. TranScrip has supported development of launch strategies, preparation and execution of publication plans, therapeutic area and product trainings, design of phase IV clinical programmes, various medical information activities and many other aspects of medical affairs.

Sharmila Kar
Head of Medical Affairs

Sharmila leads the Medical Affairs functional team within Transcrip and brings a commercially astute approach to scientific engagement activities. Sharmila has developed broad range of medical affairs project experience from working across many different therapy areas in both large and small pharma. Her experience focuses around pre-launch, post-marketing and supporting the full commercialisation of products throughout their life-cycle. She is particularly skilled at supporting market access and HEOR teams to utilise the scientific evidence to its full effect with payers and HTA bodies through effective stakeholder engagement, scientific communication and real world evidence generation.

Through her eclectic mix of experience both as an NHS GP and Medical Affairs physician in Industry, Sharmila is a results-orientated problem-solver who can communicate effectively to a wide range of external stakeholders. She is media trained and engages effectively with policy makers, clinicians and patient group representatives alike.

Functional Areas
• Medical Affairs and Commercial (including market access and outcomes research)
• Commercial Strategy and Portfolio Management

Case Study

This case study outlines TranScrip’s role in providing a medical affairs team to provide support at launch and beyond.


A pharma company in-licensed a new product in the final stages of regulatory approval but had no medical affairs team to support product launch.


TranScrip Partners assembled a team comprising a medical affairs physician supported by a medical information specialist, a medical writer and a project manager to support peri-launch activities.


The product was launched as planned and a phase IV clinical trial programme was designed and initiated.

TranScrip Partners provide Medical Affairs support across various therapeutic areas to include:

Development of medico-marketing strategies
Design of post-approval interventional & observational studies
Medical input into promotional/training materials
Medical information activities
Preparation of symposia, advisory boards, etc.
Development of publication plans and publication writing
Therapeutic area training
Complete virtual launch